Propofol: A new treatment strategy for refractory migraine headache

Pain Medicine

Volumn 3, Issue 4, 2002, Pages 366-369

  Drummond Lewis, Jacqueline ^a   Scher, Corey ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

5 HT receptors; GABAA; Migraine headache; Propofol; Receptors

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; CLONAZEPAM; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; GABAPENTIN; IBUPROFEN; LIDOCAINE; METOCLOPRAMIDE; MORPHINE; PROCHLORPERAZINE; PROMETHAZINE; PROPOFOL; TOPIRAMATE; TRAZODONE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BRAIN BLOOD VESSEL; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HEADACHE; HUMAN; MIGRAINE; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PHOTOPHOBIA; RATING SCALE; SELF REPORT; VASOCONSTRICTION;

EID: 0036927376     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2002.02034.x     Document Type: Article

References (19)

1. Krusz JC, Scott V, Belanger J. Intravenous propofol: Unique effectiveness in treating intractable migraine. Headache 2000;40:224-30.
2. Fulton B, Sorkin EM. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995;50:636-57.
3. Diprivan [professional information brochure]. Wilmington, DE: Zeneca Pharmaceuticals; 1998.
4. Ferrari MD. Migraine. Lancet 1998;351:1043-51.
5. Bateman DN. Triptans and migraine. Lancet 2000; 355:860-1.
6. Nishikawa T, Scatton B. Inhibitory influence of GABA on central serotonergic transmission. Involvement of the habernulo-raphe pathways in the GABAergic inhibition of ascending cerebral serotonergic neurons. Brain Res 1985;331:91-103.
7. Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P. Intravenous valproate sodium (depacon) aborts migraine rapidly: A preliminary report. Headache 2000;40:720-3.
8. Sanna E, Garau F, Harris RA. Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: Actions of the anesthetics propofol and pentobarbital. Mol Pharmacol 1995;47:213-7.
9. Hara M, Kai Y, Ikemoto Y. Enhancement by propofol of the gamma-aminobutyric acidA response in dissociated hippocampal pyramidal neurons of the rat. Anesthesiology 1994;81:988-94.
10. Orser BA, Bertlik M, Wang LY, MacDonald JF. Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurons. Br J Pharmacol 1995;116:1761-8.
11. Yamakura T, Sakimura K, Shimoji K, Mishina M. Effects of propofol on various AMPA- kainate- and NMDA-selective glutamate receptor channels expressed in Xenopus oocytes. Neurosci Lett 1995; 188:187-90.
12. Vandesteene A, Trempont V, Engelman E, Deloof T, Focroul M, Schoutens A, et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 1988;43 Suppl:42-3.
13. 2 reactivity of brain vessels in the human.] Anaesthesist 1987;36:60-5. German.
14. Alkire MT, Haier RJ, Barker SJ, Shah NK, Wu JC, Kao YJ. Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography. Anesthesiology 1995;82:393-403.
15. Fox J, Gelb AW, Enns J, Murkin JM, Farrar JK, Manninen PH. The responsiveness of cerebral blood flow to changes in arterial carbon dioxide is maintained during propofol-nitrous oxide anesthesia in humans. Anesthesiology 1992;77:453-6.
16. Ravussin P, Guinard JP, Ralley F, Thorin D. Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy. Anaesthesia 1998;43Suppl:37-41.
17. Maizels M. Intranasal lidocaine to prevent headache following migraine aura. Headache 1999;39:439-42.
18. Kaube H, Hoskin KL, Goadsby PJ. Lignocaine and headache: An electrophysiological study in the cat with supporting clinical observations in man. J Neurol 1994;241:415-20.
19. Bell R, Montoya D, Shuaib A, Lee MA. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990; 19:1079-82.